[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370030-105":59,"doc-detail-370030-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-application-of-tumor-organoids-an-emerging-platform-for-gynecological-cancers","Development and Application of Tumor Organoids - An Emerging Platform for Gynecological Cancers","","Gynecological cancers threaten women’s health, with ovarian cancer, cervical cancer, and endometrial cancer among the most common. Standard options such as surgery, chemotherapy, and radiotherapy are limited by drug resistance, recurrence, and variable treatment response. Tumor organoids—3D stem-cell derived cultures—preserve patient-specific morphology, marker expression, and genomic profiles while revealing heterogeneous intra- and inter-patient drug responses. This review summarizes recent advances in developing and applying tumor organoids for mechanism study, drug screening prediction, and personalized treatment in gynecological cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-application-of-tumor-organoids-an-emerging-platform-for-gynecological-cancers/370030/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-application-of-tumor-organoids-an-emerging-platform-for-gynecological-cancers/370030.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are conventional treatments for gynecological cancers often limited?","Question",{"text":112,"@type":113},"Surgery, chemotherapy, and radiotherapy can be constrained by factors such as challenging complete resection and by chemotherapy resistance, which restricts survival benefits and allows recurrence.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What advantages do tumor organoids provide in gynecological cancer research?",{"text":117,"@type":113},"Tumor organoids maintain patient tumor-dependent morphology, marker expression, and genomic profiling, and they display heterogeneous drug responses across and within patients, supporting individualized insights.",{"name":119,"@type":110,"acceptedAnswer":120},"How can tumor organoids support personalized treatment and drug screening?",{"text":121,"@type":113},"By modeling patient-specific tumor biology in a 3D culture system, organoids enable prediction of drug response and help guide personalized therapeutic strategies and screening workflows.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370030,1790621392,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","International Journal of Women’s Health  \n Open Access Full Text Article  \nDevelopment and Application of Tumor Organoids: An Emerging Platform for Gynecological Cancers  \nREVIEW  \nYu Hu 1 , *, Wei Chen 2 , *, Xiaojing Zhang 3 , *, Ying Wu4 , Furong Du 5 , Jingrui Wang 5 , Meijun He4 , Wei Sun 6  \n1Laboratory Department, the People’s Hospital of Chuxiong Yi Autonomous Prefecture & the Fourth Affiliated Hospital of Dali University, Chuxiong, Yunnan, 675000, People’s Republic of China; 2Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, People’s Republic of China; 3Reproductive Health Research Institute, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, 450000, People’s Republic of China; 4Department of Obstetrics and Gynecology, the 920th Hospital of Joint Logistics Support Force, Kunming, Yunnan, 650032, People’s Republic of China; 5Department of Medicine, Kingbio Medical Co., Ltd., Chongqing, 401123, People’s Republic of China; 6Department of General Internal Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, 030013, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Wei Sun, Department of General Internal Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, 030013, People’s Republic of China, Email [13653402236@163.com](13653402236@163.com); Meijun He, Department of Obstetrics and Gynecology, the 920th Hospital of Joint Logistics Support Force, Kunming, Yunnan, 650032, People’s Republic of China, Email [lovehmj-2008@163.com](lovehmj-2008@163.com)  \n\n| Abstract: Gynecological cancers pose great health threats to women, in which ovarian cancer (OC), cervical cancer (CC) and endometrial cancer (EC) are most common. Conventional treatment modalities for gynecological cancers, such as surgery, chemotherapy and radiotherapy, are usually affected by multiple factors like drug resistance and recurrence. Organoids, a three-dimensional culture system derived from stem cells, have been demonstrated to recapitulate the biological structure and function of human organs and gradually used in the treatment of various cancer types, including gynecological cancers. The organoids established from gynecological cancers have patient tumor-dependent morphology and disease characteristics while retaining the tumor’s marker expression and genomic profiling, and present heterogeneous inter- and intra-patient drug responses, offering novel insights into drug response of the individual patients. This review provides an overview of recent advancements in the development and application of organoids from gynecological cancers, promoting the understanding of the mechanism underlying tumorigenesis, drug screening prediction and personalized treatment application in gynecological cancers.\u003Cbr>Keywords: gynecological cancers, tumor organoids, drug screening, molecular mechanism, precision medicine |\n| --- |\n| Introduction\u003Cbr>Gynecological cancers are the unregulated growth of neoplastic cells arising in the ovaries, uterus, cervix, fallopian tubes, vulva and vagina, among which ovarian cancer (OC), cervical cancer (CC) and endometrial cancer (EC) are most common.1 According to the estimates of the International Agency for Research on Cancer, the incidence of gynecological cancers is increasing year by year, posing a serious threat to women’s lives and health.2 Currently, comprehensive approaches mainly based on surgery, chemotherapy, radiotherapy and targeted therapy are commonly used for gynecological cancers.3,4 Nevertheless, for gynecological cancers, complete surgical resection is challenging due to the unique anatomical relatio","cbCaidFg4oSq2Bl7","https://ap.wps.com/l/cbCaidFg4oSq2Bl7","pdf",2773471,13,"English","# Introduction\n## Gynecological cancers and current treatments\n## Limitations of conventional models\n# Tumor organoids overview\n## Development of patient-derived organoids\n## Applications in drug response prediction","[{\"question\":\"Why are conventional treatments for gynecological cancers often limited?\",\"answer\":\"Surgery, chemotherapy, and radiotherapy can be constrained by factors such as challenging complete resection and by chemotherapy resistance, which restricts survival benefits and allows recurrence.\"},{\"question\":\"What advantages do tumor organoids provide in gynecological cancer research?\",\"answer\":\"Tumor organoids maintain patient tumor-dependent morphology, marker expression, and genomic profiling, and they display heterogeneous drug responses across and within patients, supporting individualized insights.\"},{\"question\":\"How can tumor organoids support personalized treatment and drug screening?\",\"answer\":\"By modeling patient-specific tumor biology in a 3D culture system, organoids enable prediction of drug response and help guide personalized therapeutic strategies and screening workflows.\"}]","Development and Application of Tumor Organoids - An Emerging Platform for Gynecological Cancers | PDF",1790186302,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c864e578c8d813134567ac75c5dfb6e7.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/034c7ff4e246d4ffdedeccd282193624.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22a9c18425ffbb6c0e87b86cd8d93e73.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/201068832c9b3244989137baad790d4c.webp",980,1268]